By following through on Biden’s Medicare price negotiation program, he can take credit for prescription reductions. But Big Pharma doesn’t want that to happen.
prescription drugs
Posted inHealth and Social Policy
Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Posted inHealth and Social Policy
The Empty Hope for RFK Jr.
Taking on Big Pharma and Big Ag isn’t a one-man job.
Posted inHealth and Social Policy
Family Providers Face Barriers to Adding Abortion Services
Malpractice insurance companies have piled on numerous restrictions and jacked up their rates. It’s become a new form of restricting access to abortion.
Posted inHealth and Social Policy
FTC Sues PBMs for Jacking Up Insulin Prices
The case against Caremark, Express Scripts, and Optum Rx is the first against this element of the pharmaceutical transaction chain.
Posted inLaw and Justice
Anti-Abortion Activists Pushed Amarillo to Help Save the Mifepristone Case
Far-right legal crusader Jonathan Mitchell thought that a local ordinance was key to create standing in the Supreme Court.
Posted inEconomic Policy
Polling Shows Voters Want to See Action on Corporate Power
The problem is the poll, shared exclusively with the Prospect, also shows that voters don’t believe the Biden-Harris administration has already taken action.
Posted inEnergy and the Environment
The Inflation Reduction Act at Two
Challenges remain, but there’s been a lot of progress on restoring an industrial base, creating union jobs, and transforming our energy economy.
Posted inHealth and Social Policy
The Bipartisan Reform Opportunity Staring Kamala Harris in the Face
Both parties want to crack down on pharmacy benefit managers. The vice president could help get it done.
Posted inTAP
FTC Comes for PBMs
Today on TAP: An interim report shows how pharmaceutical middlemen raise drug prices and damage care.